These results, along with a past report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 aid the notion of focusing on ACKR3 as a novel solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Problems.A whole new review shows that the compound conolidine, l